Clinical Outcome Assessments — Second Public Discussion
Please feel free to access the slides here and recording from CP-RND’s lively Clinical Outcome Assessments webinar below. The post Clinical Outcome Assessments — Second Public Discussion appeared...
View ArticleClik here to view.
C-Path’s RDCA-DAP Announces Strategic Partnership with Vivli to Enhance...
Vivli’s Clinical Trials Data Platform and RDCA-DAP Will Make Data More Widely Accessible by Having Specific Data Sets Available on Both Platforms TUCSON, Ariz., August 20, 2024 — Critical Path...
View ArticleClik here to view.
C-Path Receives Data Transfer from The Champ Foundation Registry
The data transfer is a first for natural history data on Pearson syndrome TUCSON, Ariz., August 20, 2024 — Critical Path Institute (C-Path) has received its first data transfer of natural history...
View ArticleClik here to view.
C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in...
Peter Wipf, Ph.D. TUCSON, Ariz., August 22, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award to Peter Wipf, Ph.D.,...
View ArticleClik here to view.
C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund...
TUCSON, Ariz., August 22, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Critical Path for Lysosomal Diseases (CPLD) Consortium has been awarded a grant from the Ara Parseghian...
View ArticleClik here to view.
C-Path Announces FDA Commissioner Robert Califf to Participate in Opening...
#CGIC24 Registration Nears Capacity; Closes Saturday, Aug. 31 TUCSON, Ariz., August 30, 2024 — Critical Path Institute (C-Path) is honored to announce that FDA Commissioner Robert M. Califf, M.D.,...
View ArticleClik here to view.
American Society of Nephrology (ASN) Kidney Week 2024
American Society of Nephrology (ASN) Kidney Week 2024 BmDR Oversight Committee members Nicholas King, Katrina Peron, and Gary Friedman will be attending ASN Kidney Week 2024 in San Diego, California...
View ArticleClik here to view.
Join C-Path at the Health Research Alliance Fall Conference
C-Path’s Maaike Everts, PhD, Executive Director of its Translational Therapeutics Accelerate (TRxA), is participating in two panels at the 2024 Health Research Alliance Fall Conference. The Health...
View ArticleCystic Fibrosis Therapeutics Development Network Contributes New Data Sets to...
TUCSON, Ariz., September 5, 2024 — Critical Path Institute (C-Path) today announced the addition of significant new data sets from the Cystic Fibrosis Therapeutics Development Network (TDN),...
View ArticleClik here to view.
FDA Issues ‘Letter of Support’ Encouraging Use of Synuclein-based Biomarker,...
U.S. regulatory agency recognizes potential of alpha-synuclein seed amplification assay (αSyn-SAA) to accelerate clear outcomes in drugmakers’ trials Letter is latest milestone in the journey of the...
View ArticleClik here to view.
C-Path’s Inaugural Global Impact Conference Charts the Future of Drug...
WASHINGTON, Sept. 12, 2024 — Critical Path Institute (C-Path) successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024, at the Washington Marriott at Metro Center in...
View ArticleSteve Gleason Welcomes Guests to Day 2 of #CGIC24
Former NFL player and ALS patient advocate welcomes attendees to the second day of C-Path’s Global Impact Conference. The post Steve Gleason Welcomes Guests to Day 2 of #CGIC24 appeared first on C-Path.
View ArticleC-Path’s Translational Therapeutics Accelerator: A Unique Solution to...
The post C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development appeared first on C-Path.
View ArticleClik here to view.
C-Path’s PKD Outcomes Consortium Receives BAA Award for Project to Advance...
TUCSON, Ariz., Sept. 19, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Polycystic Kidney Disease Outcomes Consortium (PKDOC) has been awarded an Autosomal Dominant...
View ArticleClik here to view.
C-Path to Lead Comprehensive Task Force Focused on Accelerating Drug...
TUCSON, Ariz., September 30, 2024 — Critical Path Institute (C-Path) today announced the formation of a new task force under its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®),...
View ArticleClik here to view.
Access at Scientific Conferences
I want to talk about access and inclusion at scientific conferences and putting actions to words or values. Conferences are exhausting for anybody, but more so when at every turn there is an...
View ArticleClik here to view.
The AMR Accelerator Calls to Action: European Capacity for Antibiotic R&D...
Note: You are reading this information because Critical Path Institute is a partner of both ERA4TB and Unite4TB. Antibiotic resistance is a global public health threat. Modern health systems rely on...
View ArticleFlexible approaches to eCOA administration in clinical trials: The site...
Estelle Haenel, Celeste A. Elash, Katie Garner, Megan Turner, Scottie KernAbstract Electronic Clinical Outcome Assessment (eCOA) Consortium and the Patient-Reported Outcome (PRO) Consortium Abstract...
View ArticleTNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal...
Cassandra Bazile, Margy M. Abdel Malik, Courtney Ackeifi, Randy L. Anderson, Roy W. Beck, Marc Y. Donath, Sanjoy Dutta, Joseph A. Hedrick, Stephen R. Karpen, Thomas W. Kay, Thomas Marder, Marjana...
View ArticleC-Path Scientific Directors Belmonte, Kosinski to Present at 20th IDS Congress
Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present a poster titled “Development of a Tool to Optimize Clinical Trial Design...
View Article